SNDX
NASDAQ · Biotechnology
Syndax Pharmaceuticals Inc
$9.55
+0.18 (+1.92%)
Performance
1D
+0.10%
1W
-27.10%
1M
-43.49%
3M
-53.12%
6M
-55.33%
1Y
-36.50%
YTD
-55.16%
Open$9.52
Previous Close$9.37
Day High$9.79
Day Low$9.22
52W High$25.59
52W Low$9.29
Volume—
Avg Volume4.81M
Market Cap866.52M
P/E Ratio—
EPS$-2.37
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$16.33
Below
SMA 200
$20.00
Below
RSI (14)
31.6
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
18 analysts
Price Target
+156.4% upside
Current
$9.55
$9.55
Target
$24.49
$24.49
$15.15
$24.49 avg
$32.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 180.53M | 42.66M | 332.47M |
| Net Income | -298,963,700 | -516,701,989 | -96,723,913 |
| Profit Margin | -165.6% | -1,278.8% | -29.1% |
| EBITDA | -286,033,921 | -581,608,963 | -125,567,751 |
| Free Cash Flow | — | — | -63,645,585 |
| Rev Growth | — | -44.7% | -3.0% |
| Debt/Equity | 5.32 | 1.19 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |